Logo image of BG

BUNGE GLOBAL SA (BG) Stock Fundamental Analysis

NYSE:BG - New York Stock Exchange, Inc. - CH1300646267 - Common Stock - Currency: USD

77.19  -1.48 (-1.88%)

After market: 77.19 0 (0%)

Fundamental Rating

6

Overall BG gets a fundamental rating of 6 out of 10. We evaluated BG against 91 industry peers in the Food Products industry. While BG belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. BG has a bad growth rate and is valued cheaply. BG also has an excellent dividend rating. These ratings would make BG suitable for value and dividend investing!


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year BG was profitable.
In the past year BG had a positive cash flow from operations.
Of the past 5 years BG 4 years were profitable.
In the past 5 years BG reported 4 times negative operating cash flow.
BG Yearly Net Income VS EBIT VS OCF VS FCFBG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2B -2B -4B -6B

1.2 Ratios

BG's Return On Assets of 8.84% is amongst the best of the industry. BG outperforms 87.21% of its industry peers.
BG's Return On Equity of 20.67% is amongst the best of the industry. BG outperforms 88.37% of its industry peers.
BG has a better Return On Invested Capital (13.58%) than 89.53% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for BG is above the industry average of 9.02%.
The last Return On Invested Capital (13.58%) for BG is above the 3 year average (12.86%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 8.84%
ROE 20.67%
ROIC 13.58%
ROA(3y)7.99%
ROA(5y)4.3%
ROE(3y)21.59%
ROE(5y)12.18%
ROIC(3y)12.86%
ROIC(5y)10.32%
BG Yearly ROA, ROE, ROICBG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 -10 20 -20

1.3 Margins

With a Profit Margin value of 3.77%, BG perfoms like the industry average, outperforming 58.14% of the companies in the same industry.
In the last couple of years the Profit Margin of BG has grown nicely.
BG has a Operating Margin of 5.34%. This is comparable to the rest of the industry: BG outperforms 56.98% of its industry peers.
In the last couple of years the Operating Margin of BG has grown nicely.
The Gross Margin of BG (8.15%) is worse than 77.91% of its industry peers.
In the last couple of years the Gross Margin of BG has grown nicely.
Industry RankSector Rank
OM 5.34%
PM (TTM) 3.77%
GM 8.15%
OM growth 3Y17.85%
OM growth 5Y25.08%
PM growth 3Y11.64%
PM growth 5Y49.21%
GM growth 3Y6.61%
GM growth 5Y10.47%
BG Yearly Profit, Operating, Gross MarginsBG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2 -2 4 6 8

6

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so BG is still creating some value.
Compared to 1 year ago, BG has more shares outstanding
The number of shares outstanding for BG has been increased compared to 5 years ago.
BG has a worse debt/assets ratio than last year.
BG Yearly Shares OutstandingBG Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M
BG Yearly Total Debt VS Total AssetsBG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 5B 10B 15B 20B 25B

2.2 Solvency

An Altman-Z score of 4.27 indicates that BG is not in any danger for bankruptcy at the moment.
BG has a better Altman-Z score (4.27) than 83.72% of its industry peers.
The Debt to FCF ratio of BG is 2.23, which is a good value as it means it would take BG, 2.23 years of fcf income to pay off all of its debts.
BG's Debt to FCF ratio of 2.23 is fine compared to the rest of the industry. BG outperforms 74.42% of its industry peers.
BG has a Debt/Equity ratio of 0.45. This is a healthy value indicating a solid balance between debt and equity.
BG has a Debt to Equity ratio of 0.45. This is comparable to the rest of the industry: BG outperforms 50.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF 2.23
Altman-Z 4.27
ROIC/WACC1.51
WACC8.99%
BG Yearly LT Debt VS Equity VS FCFBG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5B -5B 10B

2.3 Liquidity

A Current Ratio of 2.13 indicates that BG has no problem at all paying its short term obligations.
BG has a better Current ratio (2.13) than 65.12% of its industry peers.
A Quick Ratio of 1.20 indicates that BG should not have too much problems paying its short term obligations.
BG has a better Quick ratio (1.20) than 68.60% of its industry peers.
Industry RankSector Rank
Current Ratio 2.13
Quick Ratio 1.2
BG Yearly Current Assets VS Current LiabilitesBG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 5B 10B 15B

2

3. Growth

3.1 Past

The earnings per share for BG have decreased strongly by -18.55% in the last year.
BG shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 38.94% yearly.
BG shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -11.44%.
The Revenue has been growing slightly by 5.41% on average over the past years.
EPS 1Y (TTM)-18.55%
EPS 3Y19.26%
EPS 5Y38.94%
EPS Q2Q%-23.41%
Revenue 1Y (TTM)-11.44%
Revenue growth 3Y12.87%
Revenue growth 5Y5.41%
Sales Q2Q%-9.27%

3.2 Future

BG is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -9.97% yearly.
The Revenue is expected to decrease by -0.70% on average over the next years.
EPS Next Y-29.39%
EPS Next 2Y-16.79%
EPS Next 3Y-9.97%
EPS Next 5YN/A
Revenue Next Year-10.88%
Revenue Next 2Y-4.62%
Revenue Next 3Y-0.7%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
BG Yearly Revenue VS EstimatesBG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20B 40B 60B
BG Yearly EPS VS EstimatesBG Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 5 10

8

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 7.17, which indicates a rather cheap valuation of BG.
Compared to the rest of the industry, the Price/Earnings ratio of BG indicates a rather cheap valuation: BG is cheaper than 95.35% of the companies listed in the same industry.
BG is valuated cheaply when we compare the Price/Earnings ratio to 28.58, which is the current average of the S&P500 Index.
BG is valuated reasonably with a Price/Forward Earnings ratio of 8.16.
Based on the Price/Forward Earnings ratio, BG is valued cheaper than 97.67% of the companies in the same industry.
BG is valuated cheaply when we compare the Price/Forward Earnings ratio to 24.47, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 7.17
Fwd PE 8.16
BG Price Earnings VS Forward Price EarningsBG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BG indicates a rather cheap valuation: BG is cheaper than 90.70% of the companies listed in the same industry.
88.37% of the companies in the same industry are more expensive than BG, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 4.71
EV/EBITDA 2.9
BG Per share dataBG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 100 200 300 400

4.3 Compensation for Growth

BG has a very decent profitability rating, which may justify a higher PE ratio.
BG's earnings are expected to decrease with -9.97% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)0.18
EPS Next 2Y-16.79%
EPS Next 3Y-9.97%

7

5. Dividend

5.1 Amount

BG has a Yearly Dividend Yield of 3.46%.
BG's Dividend Yield is a higher than the industry average which is at 3.85.
Compared to an average S&P500 Dividend Yield of 2.27, BG pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.46%

5.2 History

The dividend of BG has a limited annual growth rate of 4.77%.
BG has paid a dividend for at least 10 years, which is a reliable track record.
BG has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)4.77%
Div Incr Years4
Div Non Decr Years23
BG Yearly Dividends per shareBG Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2 2.5

5.3 Sustainability

BG pays out 17.08% of its income as dividend. This is a sustainable payout ratio.
DP17.08%
EPS Next 2Y-16.79%
EPS Next 3Y-9.97%
BG Yearly Income VS Free CF VS DividendBG Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2B -2B -4B -6B
BG Dividend Payout.BG Dividend Payout, showing the Payout Ratio.BG Dividend Payout.PayoutRetained Earnings

BUNGE GLOBAL SA

NYSE:BG (1/24/2025, 8:27:08 PM)

After market: 77.19 0 (0%)

77.19

-1.48 (-1.88%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)10-30 2024-10-30/bmo
Earnings (Next)02-05 2025-02-05/bmo
Inst Owners89.25%
Inst Owner Change0.09%
Ins Owners0.92%
Ins Owner Change0.11%
Market Cap10.30B
Analysts78.95
Price Target108.77 (40.91%)
Short Float %3.54%
Short Ratio2.45
Dividend
Industry RankSector Rank
Dividend Yield 3.46%
Yearly Dividend2.77
Dividend Growth(5Y)4.77%
DP17.08%
Div Incr Years4
Div Non Decr Years23
Ex-Date02-18 2025-02-18 (0.68)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)22.16%
Min EPS beat(2)16.26%
Max EPS beat(2)28.05%
EPS beat(4)3
Avg EPS beat(4)19.05%
Min EPS beat(4)-2.41%
Max EPS beat(4)34.32%
EPS beat(8)5
Avg EPS beat(8)17.17%
EPS beat(12)9
Avg EPS beat(12)38.71%
EPS beat(16)12
Avg EPS beat(16)95.75%
Revenue beat(2)0
Avg Revenue beat(2)-6.77%
Min Revenue beat(2)-9.85%
Max Revenue beat(2)-3.69%
Revenue beat(4)1
Avg Revenue beat(4)-5.93%
Min Revenue beat(4)-10.88%
Max Revenue beat(4)0.68%
Revenue beat(8)3
Avg Revenue beat(8)-4.42%
Revenue beat(12)6
Avg Revenue beat(12)1.79%
Revenue beat(16)7
Avg Revenue beat(16)0.97%
PT rev (1m)-0.93%
PT rev (3m)-7.78%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.62%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0.02%
Revenue NY rev (3m)-1.91%
Valuation
Industry RankSector Rank
PE 7.17
Fwd PE 8.16
P/S 0.17
P/FCF 4.71
P/OCF 3.11
P/B 0.95
P/tB 1.03
EV/EBITDA 2.9
EPS(TTM)10.76
EY13.94%
EPS(NY)9.46
Fwd EY12.26%
FCF(TTM)16.38
FCFY21.22%
OCF(TTM)24.78
OCFY32.11%
SpS446.06
BVpS81.29
TBVpS74.65
PEG (NY)N/A
PEG (5Y)0.18
Profitability
Industry RankSector Rank
ROA 8.84%
ROE 20.67%
ROCE 17.99%
ROIC 13.58%
ROICexc 16.56%
ROICexgc 17.59%
OM 5.34%
PM (TTM) 3.77%
GM 8.15%
FCFM 3.67%
ROA(3y)7.99%
ROA(5y)4.3%
ROE(3y)21.59%
ROE(5y)12.18%
ROIC(3y)12.86%
ROIC(5y)10.32%
ROICexc(3y)15.13%
ROICexc(5y)11.93%
ROICexgc(3y)16.14%
ROICexgc(5y)12.82%
ROCE(3y)17%
ROCE(5y)14%
ROICexcg growth 3Y28.52%
ROICexcg growth 5Y24.42%
ROICexc growth 3Y29.5%
ROICexc growth 5Y26.05%
OM growth 3Y17.85%
OM growth 5Y25.08%
PM growth 3Y11.64%
PM growth 5Y49.21%
GM growth 3Y6.61%
GM growth 5Y10.47%
F-Score7
Asset Turnover2.35
Health
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF 2.23
Debt/EBITDA 1.34
Cap/Depr 248.78%
Cap/Sales 1.88%
Interest Coverage 6.27
Cash Conversion 91.08%
Profit Quality 97.46%
Current Ratio 2.13
Quick Ratio 1.2
Altman-Z 4.27
F-Score7
WACC8.99%
ROIC/WACC1.51
Cap/Depr(3y)159.64%
Cap/Depr(5y)131.69%
Cap/Sales(3y)1.13%
Cap/Sales(5y)1.11%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-18.55%
EPS 3Y19.26%
EPS 5Y38.94%
EPS Q2Q%-23.41%
EPS Next Y-29.39%
EPS Next 2Y-16.79%
EPS Next 3Y-9.97%
EPS Next 5YN/A
Revenue 1Y (TTM)-11.44%
Revenue growth 3Y12.87%
Revenue growth 5Y5.41%
Sales Q2Q%-9.27%
Revenue Next Year-10.88%
Revenue Next 2Y-4.62%
Revenue Next 3Y-0.7%
Revenue Next 5YN/A
EBIT growth 1Y31.56%
EBIT growth 3Y33.02%
EBIT growth 5Y31.85%
EBIT Next Year-11.3%
EBIT Next 3Y-3.69%
EBIT Next 5YN/A
FCF growth 1Y135.81%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y159.61%
OCF growth 3YN/A
OCF growth 5YN/A